This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Kaustabh Kumar Maiti: Innovator in Molecular Transporters
Introduction
Kaustabh Kumar Maiti is a prominent inventor based in Pohang, South Korea. He has made significant contributions to the field of molecular transporters, particularly focusing on compounds that enhance the permeability of biological membranes. With a total of 5 patents to his name, Maiti is recognized for his innovative approaches to delivering biologically active molecules.
Latest Patents
Maiti's latest patents include groundbreaking work on molecular transporters based on sugar and its analogues. These inventive molecular transporter compounds demonstrate significantly high permeability through various biological membranes, such as the plasma membrane, nuclear membrane, and blood-brain barrier. This high permeability allows for effective delivery of various biologically active molecules, showcasing the potential of his inventions in medical and pharmaceutical applications.
Career Highlights
Maiti is affiliated with the Pohang University of Science and Technology Foundation, where he continues to advance research in molecular transporters. His work has garnered attention for its potential to revolutionize drug delivery systems and improve therapeutic outcomes.
Collaborations
Maiti collaborates with esteemed colleagues, including Sung-Kee Chung and Woo Sirl Lee. These partnerships enhance the research environment and contribute to the innovative projects being developed at the university.
Conclusion
Kaustabh Kumar Maiti is a leading figure in the development of molecular transporters, with a focus on enhancing drug delivery through innovative compounds. His contributions to the field are paving the way for future advancements in biotechnology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile